Episurf Medical AB will be exhibiting at 27. Berliner Arthroskopiekurs, held in Berlin, Germany, on April 21-22

Episurf Medical AB will participate at 27. Berliner Arthroskopiekurs, an orthopaedic conference held in Berlin, Germany, (Tagungszentrum Hotel Aquino) on April 21-22 and the event is arranged by Berliner Kliniken und Praxen.

For full program, see link. ( http://www.arthroskopie-berlin.de/berlin/) ). For an overview of the industry conferences attended by Episurf Medical, see link. ( www.episurf.com/healthcare-professionals/conferences ).

For more information, please contact:

Pål Ryfors, acting CEO, Episurf Medical

Tel: +46 (0) 709 62 36 69

Email:  pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 16.15 CET on 4 April 2017.

Tags:

About Us

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.